Jefferies Group’s Guardant Health GH Stock Holding History

Jefferies Group’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.85M	Buy	34,300 +20,000	+140%	+$1.03M	0.02%	638
2022 Q2	$577K	Buy	+14,300	New	+$709K	﹤0.01%	948
2022 Q1	–	Sell	-61,700	Closed	-$6.17M	–	1675
2021 Q4	$6.17M	Buy	61,700 +60,200	+4,013%	+$6.23M	0.04%	401
2021 Q3	$188K	Sell	1,500 -5,000	-77%	-$594K	﹤0.01%	1475
2021 Q2	$807K	Buy	6,500 +1,500	+30%	+$202K	0.01%	1053
2021 Q1	$763K	Buy	+5,000	New	+$756K	0.01%	986
2019 Q4	–	Sell	-9,500	Closed	-$606K	–	2706
2019 Q3	$606K	Buy	9,500 +3,300	+53%	+$291K	﹤0.01%	1779
2019 Q2	$535K	Sell	6,200 -7,300	-54%	-$558K	﹤0.01%	1634
2019 Q1	$1.03M	Buy	+13,500	New	+$748K	0.01%	1255

Other funds holding GH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jefferies Group's GH Position: Q3 2022 in Review

Jefferies Group reduced its Guardant Health (GH) stake by 22% in Q3 2022, selling an estimated $709K and leaving 50,228 shares worth $2.7M. The position accounts for 0.02% of the portfolio, ranked #511.

Jefferies Group first reported a position in GH in Q1 2019 and has held it in 13 quarters since. The position peaked at $4.39M in Q1 2021. 327 funds tracked by Wall St. Rank hold GH as of Q3 2022.

Jefferies Group held 50,228 shares of Guardant Health worth $2.7M as of Q3 2022.
Jefferies Group sold 13,805 Guardant Health shares in Q3 2022, an estimated $709K.
Guardant Health made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #511 holding.
Jefferies Group first reported a position in Guardant Health in Q1 2019 and has held it in 13 quarters since.
Jefferies Group's Guardant Health position peaked at $4.39M in Q1 2021.
327 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.